| P2093 | author name string | Broderick PA | |
| | Hope O | |
| | Jeannot P | |
| P2860 | cites work | Determination of biological activity of adinazolam and its metabolites | Q28261651 |
| | Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine | Q28265828 |
| | A single amino acid of the human gamma-aminobutyric acid type A receptor gamma 2 subunit determines benzodiazepine efficacy | Q28304675 |
| | Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment | Q28322232 |
| | 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity | Q34229387 |
| | Management of depression with serotonin precursors | Q34249075 |
| | Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium | Q35899183 |
| | Structure and function of the brain serotonin system | Q36741599 |
| | Antidepressant medications. A more effective use by general practitioners, family physicians, internists, and others. | Q54346774 |
| | Inhibition of fighting in isolated mice following repeated administration of lithium chloride | Q67015914 |
| | Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects | Q67584215 |
| | Distinguishing in vitro electrochemical signatures for norepinephrine and dopamine | Q68032747 |
| | Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients | Q68204800 |
| | Diabetes-Related Changes in L-Tryptophan–Induced Release of Striatal Biogenic Amines | Q68412635 |
| | Electrically evoked noradrenaline release in the rat hypothalamic paraventricular nucleus studied by in vivo electrochemistry: autoregulation by alpha-2 receptors | Q68457924 |
| | A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor | Q69173115 |
| | Characterizing stearate probes in vitro for the electrochemical detection of dopamine and serotonin | Q69719044 |
| | Variability of response to lithium augmentation in refractory depression | Q70311099 |
| | Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment | Q71263874 |
| | Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo | Q71539024 |
| | Relationship between concentrations of adinazolam and its primary metabolite in plasma and therapeutic/untoward effects in the treatment of panic disorder | Q72347552 |
| | 1-(Aminoalkyl)-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with antianxiety and antidepressant activity | Q72424882 |
| | Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine | Q72467721 |
| | Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus | Q72859814 |
| | Effect of norepinephrine uptake blocker on beta-adrenergic receptors of the rat cerebral cortex | Q72917638 |
| | Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder | Q72932715 |
| | Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells | Q72954453 |
| | Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan | Q76468054 |
| | Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression | Q38734151 |
| | A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: Demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase | Q39158701 |
| | Benzodiazepines: Potentiation of a GABA inhibitory response in the dorsal raphe nucleus | Q39196019 |
| | Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines | Q39223107 |
| | Therapeutic effects of serotonin uptake inhibitors in depression | Q39477973 |
| | Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression | Q39690746 |
| | A review of controlled studies of adinazolam mesylate in patients with major depressive disorder | Q39737667 |
| | Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment | Q40200880 |
| | Current concepts in psychiatry. Panic attacks and phobias | Q40332864 |
| | Long-term drug treatment of panic disorder | Q40621957 |
| | Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents | Q40697751 |
| | Benzodiazepines as antidepressants: does GABA play a role in depression? | Q40952779 |
| | Newer antidepressants and the cytochrome P450 system | Q40976263 |
| | Social phobia: everyone's disorder? | Q40997076 |
| | Benzodiazepines on trial: a research strategy for their rehabilitation | Q41008175 |
| | Identification of functional platelet-activating factor receptors on human keratinocytes | Q41268808 |
| | Use of benzodiazepines in panic disorder. | Q41393306 |
| | Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone | Q41452000 |
| | I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT--DA interaction in cocaine dysfunctional behavior. | Q41485856 |
| | The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. | Q41489625 |
| | Neurotransmitters in Anxiety | Q41533168 |
| | Deamplification of noradrenergic signal transfer by antidepressants: a unified catecholamine-serotonin hypothesis of affective disorders. | Q41588512 |
| | Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites | Q42201455 |
| | The effects of chronic antidepressant treatment in an animal model of anxiety | Q42209089 |
| | Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration | Q42505275 |
| | Adinazolam affects biogenic amine release in hippocampal CA1 neuronal circuitry | Q43745765 |
| | Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze | Q44025232 |
| | Distinguishing effects of cocaine i.v. and SC on mesoaccumbens dopamineand serotonin release with chloral hydrate anesthesia | Q45100305 |
| | In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus | Q48328090 |
| | Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow | Q48520501 |
| | Alprazolam, diazepam, yohimbine, clonidine: in vivo CA1 hippocampal norepinephrine and serotonin release profiles under chloral hydrate anesthesia | Q48569105 |
| | In vivo voltammetric studies on release mechanisms for cocaine with gamma-butyrolactone | Q48614434 |
| | 5-HT1A agonists uncouple noradrenergic somatodendritic impulse flow and terminal release | Q48635607 |
| | Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine | Q48686720 |
| | 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. | Q48710062 |
| | Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum | Q48738243 |
| | The effect of chronic alprazolam on sleep and bioamine metabolites in depression | Q48852721 |
| | Behavioral and biochemical changes induced by lithium and l-tryptophan in muricidal rats | Q48930628 |
| | Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison | Q48959222 |
| | Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder | Q49026710 |
| | Electrically evoked noradrenaline release in the rat hypothalamic paraventricular nucleus studied by in vivo electrochemistry: characterization and facilitation by increasing the stimulation frequency. | Q49161448 |
| | VARIOUS SEIZURE ACTIVITIES FOLLOWING GAMMA-HYDROXYBUTYRATE. | Q50675982 |
| | Recent developments in 5HT-related pharmacology of animal models of anxiety. | Q51211811 |
| | Panic disorders: current perspectives. | Q51246076 |
| | Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. | Q51246081 |
| | Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study | Q51252434 |
| | Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. | Q51271294 |
| | Potentiation of the antidepressant action of clomipramine by tryptophan | Q51290103 |
| | Adinazolam, a fast-acting antidepressant, is tolerated during general anesthesia. | Q51773399 |
| | Effect of chronic administration of alprazolam and adinazolam on clonidine- or apomorphine-induced aggression in laboratory rodents. | Q51806669 |
| | Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine. | Q51847565 |
| | Alprazolam in a biochemical model of depression | Q51859177 |
| | [Effects of co-administration of an antidepressant and an anxiolytic drug in the "learned helplessness" paradigm: importance of hydroxyzine] | Q52200672 |
| | Clinical aspects of chronic use of alprazolam and lorazepam. | Q52271478 |
| P433 | issue | 2 | |
| P921 | main subject | serotonin | Q167934 |
| | norepinephrine | Q186242 |
| P304 | page(s) | 353-386 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal | |
| P478 | volume | 22 | |